Clinical Trial Update: Evaluating the Safety and Immune Response to a Live H7N9 Influenza Virus Vaccine Followed by an Inactivated H7N9 Influenza Virus Vaccine, Given at Varying Intervals [Phase 1]

View source ↗

Summary

Phase 1 trial assessing the safety and immune response of a live H7N9 influenza vaccine followed by an inactivated H7N9 influenza vaccine given at different int…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Influenza Virus Infection H7n9 Subtype

Drugs mentioned

• Inactivated H7N9 influenza vaccine
• Live H7N9 influenza vaccine

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Influenza A Virus, H7N9 Subtype | Phase 1 | Status: COMPLETED